The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Exosome Marker Antibodies Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2029
Synopsis
The global Exosome Marker Antibodies market size was valued at USD 476.4 million in 2022 and is forecast to a readjusted size of USD 948.4 million by 2029 with a CAGR of 10.3% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Exosomes are small vesicles composed of a lipid bilayer. Exosomes are formed when certain endosomes, called multivesicular bodies, fuse with the plasma membrane, releasing them into the extracellular environment. They may also be directly released from the plasma membrane. Exosomal marker antibodies are designed to dependably detect the key exosomal targets.
This report is a detailed and comprehensive analysis for global Exosome Marker Antibodies market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Exosome Marker Antibodies market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Exosome Marker Antibodies market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Exosome Marker Antibodies market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Exosome Marker Antibodies market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Exosome Marker Antibodies
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Exosome Marker Antibodies market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novus Biologicals, Thermo Fisher Scientific, System Biosciences, Creative Bioarray and MBL International, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Exosome Marker Antibodies market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Tetraspanins
Multivesicular Body (MVB)-Associated Proteins
Others
Market segment by Application
Academic and Research Institutes
Pharmaceutical and Biotechnology Company
Hospitals and Clinical
Testing Laboratories
Others
Major players covered
Novus Biologicals
Thermo Fisher Scientific
System Biosciences
Creative Bioarray
MBL International
FUJIFILM Wako
Qiagen
Miltenyi Biotech
Beckman Coulter
ABP Biosciences
BioVision
Alpha Laboratories
BioCat GmbH
RayBiotech
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Exosome Marker Antibodies product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Exosome Marker Antibodies, with price, sales, revenue and global market share of Exosome Marker Antibodies from 2018 to 2023.
Chapter 3, the Exosome Marker Antibodies competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Exosome Marker Antibodies breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Exosome Marker Antibodies market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Exosome Marker Antibodies.
Chapter 14 and 15, to describe Exosome Marker Antibodies sales channel, distributors, customers, research findings and conclusion.
The global Exosome Marker Antibodies market size was valued at USD 476.4 million in 2022 and is forecast to a readjusted size of USD 948.4 million by 2029 with a CAGR of 10.3% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Exosomes are small vesicles composed of a lipid bilayer. Exosomes are formed when certain endosomes, called multivesicular bodies, fuse with the plasma membrane, releasing them into the extracellular environment. They may also be directly released from the plasma membrane. Exosomal marker antibodies are designed to dependably detect the key exosomal targets.
This report is a detailed and comprehensive analysis for global Exosome Marker Antibodies market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Exosome Marker Antibodies market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Exosome Marker Antibodies market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Exosome Marker Antibodies market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Exosome Marker Antibodies market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Exosome Marker Antibodies
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Exosome Marker Antibodies market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novus Biologicals, Thermo Fisher Scientific, System Biosciences, Creative Bioarray and MBL International, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Exosome Marker Antibodies market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Tetraspanins
Multivesicular Body (MVB)-Associated Proteins
Others
Market segment by Application
Academic and Research Institutes
Pharmaceutical and Biotechnology Company
Hospitals and Clinical
Testing Laboratories
Others
Major players covered
Novus Biologicals
Thermo Fisher Scientific
System Biosciences
Creative Bioarray
MBL International
FUJIFILM Wako
Qiagen
Miltenyi Biotech
Beckman Coulter
ABP Biosciences
BioVision
Alpha Laboratories
BioCat GmbH
RayBiotech
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Exosome Marker Antibodies product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Exosome Marker Antibodies, with price, sales, revenue and global market share of Exosome Marker Antibodies from 2018 to 2023.
Chapter 3, the Exosome Marker Antibodies competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Exosome Marker Antibodies breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Exosome Marker Antibodies market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Exosome Marker Antibodies.
Chapter 14 and 15, to describe Exosome Marker Antibodies sales channel, distributors, customers, research findings and conclusion.
Index1 Market Overview
1.1 Product Overview and Scope of Exosome Marker Antibodies
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Exosome Marker Antibodies Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Tetraspanins
1.3.3 Multivesicular Body (MVB)-Associated Proteins
1.3.4 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Exosome Marker Antibodies Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Academic and Research Institutes
1.4.3 Pharmaceutical and Biotechnology Company
1.4.4 Hospitals and Clinical
1.4.5 Testing Laboratories
1.4.6 Others
1.5 Global Exosome Marker Antibodies Market Size & Forecast
1.5.1 Global Exosome Marker Antibodies Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Exosome Marker Antibodies Sales Quantity (2018-2029)
1.5.3 Global Exosome Marker Antibodies Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Novus Biologicals
2.1.1 Novus Biologicals Details
2.1.2 Novus Biologicals Major Business
2.1.3 Novus Biologicals Exosome Marker Antibodies Product and Services
2.1.4 Novus Biologicals Exosome Marker Antibodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Novus Biologicals Recent Developments/Updates
2.2 Thermo Fisher Scientific
2.2.1 Thermo Fisher Scientific Details
2.2.2 Thermo Fisher Scientific Major Business
2.2.3 Thermo Fisher Scientific Exosome Marker Antibodies Product and Services
2.2.4 Thermo Fisher Scientific Exosome Marker Antibodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Thermo Fisher Scientific Recent Developments/Updates
2.3 System Biosciences
2.3.1 System Biosciences Details
2.3.2 System Biosciences Major Business
2.3.3 System Biosciences Exosome Marker Antibodies Product and Services
2.3.4 System Biosciences Exosome Marker Antibodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 System Biosciences Recent Developments/Updates
2.4 Creative Bioarray
2.4.1 Creative Bioarray Details
2.4.2 Creative Bioarray Major Business
2.4.3 Creative Bioarray Exosome Marker Antibodies Product and Services
2.4.4 Creative Bioarray Exosome Marker Antibodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Creative Bioarray Recent Developments/Updates
2.5 MBL International
2.5.1 MBL International Details
2.5.2 MBL International Major Business
2.5.3 MBL International Exosome Marker Antibodies Product and Services
2.5.4 MBL International Exosome Marker Antibodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 MBL International Recent Developments/Updates
2.6 FUJIFILM Wako
2.6.1 FUJIFILM Wako Details
2.6.2 FUJIFILM Wako Major Business
2.6.3 FUJIFILM Wako Exosome Marker Antibodies Product and Services
2.6.4 FUJIFILM Wako Exosome Marker Antibodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 FUJIFILM Wako Recent Developments/Updates
2.7 Qiagen
2.7.1 Qiagen Details
2.7.2 Qiagen Major Business
2.7.3 Qiagen Exosome Marker Antibodies Product and Services
2.7.4 Qiagen Exosome Marker Antibodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Qiagen Recent Developments/Updates
2.8 Miltenyi Biotech
2.8.1 Miltenyi Biotech Details
2.8.2 Miltenyi Biotech Major Business
2.8.3 Miltenyi Biotech Exosome Marker Antibodies Product and Services
2.8.4 Miltenyi Biotech Exosome Marker Antibodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Miltenyi Biotech Recent Developments/Updates
2.9 Beckman Coulter
2.9.1 Beckman Coulter Details
2.9.2 Beckman Coulter Major Business
2.9.3 Beckman Coulter Exosome Marker Antibodies Product and Services
2.9.4 Beckman Coulter Exosome Marker Antibodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Beckman Coulter Recent Developments/Updates
2.10 ABP Biosciences
2.10.1 ABP Biosciences Details
2.10.2 ABP Biosciences Major Business
2.10.3 ABP Biosciences Exosome Marker Antibodies Product and Services
2.10.4 ABP Biosciences Exosome Marker Antibodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 ABP Biosciences Recent Developments/Updates
2.11 BioVision
2.11.1 BioVision Details
2.11.2 BioVision Major Business
2.11.3 BioVision Exosome Marker Antibodies Product and Services
2.11.4 BioVision Exosome Marker Antibodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 BioVision Recent Developments/Updates
2.12 Alpha Laboratories
2.12.1 Alpha Laboratories Details
2.12.2 Alpha Laboratories Major Business
2.12.3 Alpha Laboratories Exosome Marker Antibodies Product and Services
2.12.4 Alpha Laboratories Exosome Marker Antibodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Alpha Laboratories Recent Developments/Updates
2.13 BioCat GmbH
2.13.1 BioCat GmbH Details
2.13.2 BioCat GmbH Major Business
2.13.3 BioCat GmbH Exosome Marker Antibodies Product and Services
2.13.4 BioCat GmbH Exosome Marker Antibodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 BioCat GmbH Recent Developments/Updates
2.14 RayBiotech
2.14.1 RayBiotech Details
2.14.2 RayBiotech Major Business
2.14.3 RayBiotech Exosome Marker Antibodies Product and Services
2.14.4 RayBiotech Exosome Marker Antibodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 RayBiotech Recent Developments/Updates
3 Competitive Environment: Exosome Marker Antibodies by Manufacturer
3.1 Global Exosome Marker Antibodies Sales Quantity by Manufacturer (2018-2023)
3.2 Global Exosome Marker Antibodies Revenue by Manufacturer (2018-2023)
3.3 Global Exosome Marker Antibodies Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Exosome Marker Antibodies by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Exosome Marker Antibodies Manufacturer Market Share in 2022
3.4.2 Top 6 Exosome Marker Antibodies Manufacturer Market Share in 2022
3.5 Exosome Marker Antibodies Market: Overall Company Footprint Analysis
3.5.1 Exosome Marker Antibodies Market: Region Footprint
3.5.2 Exosome Marker Antibodies Market: Company Product Type Footprint
3.5.3 Exosome Marker Antibodies Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Exosome Marker Antibodies Market Size by Region
4.1.1 Global Exosome Marker Antibodies Sales Quantity by Region (2018-2029)
4.1.2 Global Exosome Marker Antibodies Consumption Value by Region (2018-2029)
4.1.3 Global Exosome Marker Antibodies Average Price by Region (2018-2029)
4.2 North America Exosome Marker Antibodies Consumption Value (2018-2029)
4.3 Europe Exosome Marker Antibodies Consumption Value (2018-2029)
4.4 Asia-Pacific Exosome Marker Antibodies Consumption Value (2018-2029)
4.5 South America Exosome Marker Antibodies Consumption Value (2018-2029)
4.6 Middle East and Africa Exosome Marker Antibodies Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Exosome Marker Antibodies Sales Quantity by Type (2018-2029)
5.2 Global Exosome Marker Antibodies Consumption Value by Type (2018-2029)
5.3 Global Exosome Marker Antibodies Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Exosome Marker Antibodies Sales Quantity by Application (2018-2029)
6.2 Global Exosome Marker Antibodies Consumption Value by Application (2018-2029)
6.3 Global Exosome Marker Antibodies Average Price by Application (2018-2029)
7 North America
7.1 North America Exosome Marker Antibodies Sales Quantity by Type (2018-2029)
7.2 North America Exosome Marker Antibodies Sales Quantity by Application (2018-2029)
7.3 North America Exosome Marker Antibodies Market Size by Country
7.3.1 North America Exosome Marker Antibodies Sales Quantity by Country (2018-2029)
7.3.2 North America Exosome Marker Antibodies Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Exosome Marker Antibodies Sales Quantity by Type (2018-2029)
8.2 Europe Exosome Marker Antibodies Sales Quantity by Application (2018-2029)
8.3 Europe Exosome Marker Antibodies Market Size by Country
8.3.1 Europe Exosome Marker Antibodies Sales Quantity by Country (2018-2029)
8.3.2 Europe Exosome Marker Antibodies Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Exosome Marker Antibodies Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Exosome Marker Antibodies Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Exosome Marker Antibodies Market Size by Region
9.3.1 Asia-Pacific Exosome Marker Antibodies Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Exosome Marker Antibodies Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Exosome Marker Antibodies Sales Quantity by Type (2018-2029)
10.2 South America Exosome Marker Antibodies Sales Quantity by Application (2018-2029)
10.3 South America Exosome Marker Antibodies Market Size by Country
10.3.1 South America Exosome Marker Antibodies Sales Quantity by Country (2018-2029)
10.3.2 South America Exosome Marker Antibodies Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Exosome Marker Antibodies Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Exosome Marker Antibodies Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Exosome Marker Antibodies Market Size by Country
11.3.1 Middle East & Africa Exosome Marker Antibodies Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Exosome Marker Antibodies Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Exosome Marker Antibodies Market Drivers
12.2 Exosome Marker Antibodies Market Restraints
12.3 Exosome Marker Antibodies Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Exosome Marker Antibodies and Key Manufacturers
13.2 Manufacturing Costs Percentage of Exosome Marker Antibodies
13.3 Exosome Marker Antibodies Production Process
13.4 Exosome Marker Antibodies Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Exosome Marker Antibodies Typical Distributors
14.3 Exosome Marker Antibodies Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
